Hyperion DeFi, Inc. (HYPD)
3.40
+0.04
(+1.04%)
USD |
NASDAQ |
Oct 09, 16:00
3.41
+0.01
(+0.29%)
After-Hours: 20:00
Hyperion DeFi Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | 38.90% |
| September 30, 2025 | |
| June 30, 2025 | |
| March 31, 2025 | -414.3% |
| December 31, 2024 | -11.70K% |
| September 30, 2024 | -26.24K% |
| June 30, 2024 | -3.37K% |
| March 31, 2024 | -6.63K% |
| December 31, 2023 | -10.67K% |
| September 30, 2023 | -26.53K% |
| June 30, 2023 |
| Date | Value |
|---|---|
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 99.27% |
| September 30, 2021 | |
| June 30, 2021 | 57.90% |
| March 31, 2021 | 58.34% |
| December 31, 2020 | 58.81% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Omeros Corp. | 96.50% |
| Talphera, Inc. | -- |
| ANI Pharmaceuticals, Inc. | 54.97% |
| Corcept Therapeutics, Inc. | 98.41% |
| Veru, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 10.74% |
| Return on Assets | 8.91% |
| Return on Invested Capital | 9.42% |
| Operating Margin (Quarterly) | -757.5% |
| Return on Net Operating Assets | 25.80% |